Piper Jaffray Downgrades Gen-Probe (GPRO) to Neutral
Tweet Send to a FriendGet Alerts GPRO Hot Sheet
Price: $82.69 --0%
Rating Summary:
4 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
4 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade GPRO Now!
Piper Jaffray's William Quirk downgraded shares of Gen-Probe (NASDAQ: GPRO) from Overweight to Neutral Monday afternoon following news of the company's $3.7 billion deal with Hologic (Nasdaq: HOLX). The analyst boosted his price target on Gen-Probe shares from $80 to $82.75.
Gen-Probe shares last traded at $81.59, up 18.7 percent from Friday's closing price.
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Gen-Probe shares last traded at $81.59, up 18.7 percent from Friday's closing price.
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- SunTrust Robinson Humphrey Downgrades Stryker (SYK) to Reduce
- RBC Capital Downgrades MeadWestvaco (MWV) to Underperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
